Actively Recruiting
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Led by Radicle Science · Updated on 2026-01-23
825
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Radicle GI Health DBG: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.
CONDITIONS
Official Title
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 21 years of age or older at the time of electronic consent
- Reside in the United States
- Have the opportunity for at least 30% improvement in their primary health outcome
- Willing to take a study product without knowing if it is active or placebo until the study ends
You will not qualify if you...
- Pregnant, trying to become pregnant, or breastfeeding
- Unable to provide a valid US shipping address and mobile phone number
- Unable to verify identity using Veriff during consent
- Currently enrolled in another clinical trial
- Heavy drinker (3 or more alcoholic beverages per day)
- Unable to read and understand English at approximately a 7th grade level
- Current or recent major illness or surgery within 3 months posing significant safety risk
- Diagnosis of cardiac dysfunction, liver or kidney disease with known contraindications or safety risks (including NYHA Class III or IV heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure)
- Taking medications with moderate or severe interactions posing substantial safety risk with study product ingredients (including anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, grapefruit-warning medications, corticosteroids over 5 mg/day, diabetic medications, oral anti-infectives for acute infection, antipsychotics, MAOIs, or thyroid products)
- Current use of primary ingredient(s) or similar products to the active study product(s) that may limit effects or pose safety risks
- Lack of reliable daily internet access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Radicle Science Inc.
Del Mar, California, United States, 92014
Actively Recruiting
Research Team
S
Study Manager
CONTACT
S
Susan Hewlings
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here